(Q61818478)

3

object named as

Linlin Bao

0 references

author name string

Zhiqi Song

1

0 references

Yanfeng Xu

2

0 references

Ling Zhang

4

0 references

Pin Yu

5

0 references

Yajin Qu

6

0 references

Hua Zhu

7

0 references

Wenjie Zhao

8

0 references

Yunlin Han

Creative Commons Attribution

9

0 references

language of work or name

English

0 references

publication date

14 January 2019

6 references

3 November 2019

27 April 2020

1 July 2020

24 August 2020

13 July 2022

22 October 2022

6 references

3 November 2019

27 April 2020

1 July 2020

24 August 2020

13 July 2022

22 October 2022

11

0 references

issue

1

0 references

page(s)

59

0 references

copyright license

6 references

3 November 2019

27 April 2020

1 July 2020

24 August 2020

13 July 2022

22 October 2022

0 references

A major outbreak of severe acute respiratory syndrome in Hong Kong

1 reference

12 December 2020

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

12 December 2020

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

The Genome sequence of the SARS-associated coronavirus

1 reference

12 December 2020

SARS-Associated Coronavirus

1 reference

12 December 2020

Aetiology: Koch's postulates fulfilled for SARS virus

1 reference

12 December 2020

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.

1 reference

12 December 2020

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.

1 reference

12 December 2020

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China

1 reference

12 December 2020

Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003.

1 reference

12 December 2020

Virology: SARS virus infection of cats and ferrets

1 reference

12 December 2020

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

12 December 2020

The SARS-CoV S glycoprotein: expression and functional characterization

1 reference

12 December 2020

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

1 reference

12 December 2020

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

1 reference

12 December 2020

Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice

1 reference

12 December 2020

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

1 reference

12 December 2020

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors

1 reference

12 December 2020

Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection

1 reference

12 December 2020

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

1 reference

12 December 2020

Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core

1 reference

12 December 2020

pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN

1 reference

12 December 2020

Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways

1 reference

12 December 2020

Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.

1 reference

12 December 2020

S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients

1 reference

12 December 2020

The life cycle of SARS coronavirus in Vero E6 cells

1 reference

12 December 2020

Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein

1 reference

12 December 2020

An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies

1 reference

12 December 2020

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS.

1 reference

12 December 2020

Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets

1 reference

12 December 2020

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus.

1 reference

12 December 2020

Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection.

1 reference

12 December 2020

Mice susceptible to SARS coronavirus

1 reference

12 December 2020

Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core.

1 reference

12 December 2020

Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice

1 reference

12 December 2020

Macaque model for severe acute respiratory syndrome

1 reference

12 December 2020

Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1.

1 reference

12 December 2020

Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2.

1 reference

12 December 2020

CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus

1 reference

12 December 2020

Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets

1 reference

12 December 2020

Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys.

1 reference

12 December 2020

Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters

1 reference

12 December 2020

Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus

1 reference

12 December 2020

Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice

1 reference

12 December 2020

Severe acute respiratory syndrome (SARS): a year in review.

1 reference

12 December 2020

Acute renal impairment in coronavirus-associated severe acute respiratory syndrome.

1 reference

12 December 2020

Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates

1 reference

12 December 2020

Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.

1 reference

12 December 2020

Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents

1 reference

12 December 2020

Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines

1 reference

12 December 2020

Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets

1 reference

12 December 2020

Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein

1 reference

12 December 2020

Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2.

1 reference

12 December 2020

Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans

1 reference

12 December 2020

Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein

1 reference

12 December 2020

An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus

1 reference

12 December 2020

Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus

1 reference

12 December 2020

A molecular docking model of SARS-CoV S1 protein in complex with its receptor, human ACE2.

1 reference

12 December 2020

Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy.

1 reference

12 December 2020

SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus.

1 reference

12 December 2020

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

1 reference

12 December 2020

Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine

1 reference

12 December 2020

Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus

1 reference

12 December 2020

SARS vaccine protective in mice

1 reference

12 December 2020

Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque

1 reference

12 December 2020

A serological survey on neutralizing antibody titer of SARS convalescent sera

1 reference

12 December 2020

Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV).

1 reference

12 December 2020

Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library.

1 reference

12 December 2020

Structure of SARS coronavirus spike receptor-binding domain complexed with receptor

1 reference

12 December 2020

A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses

1 reference

12 December 2020

SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens

1 reference

12 December 2020

SARS: clinical presentation, transmission, pathogenesis and treatment options

1 reference

12 December 2020

The expression of membrane protein augments the specific responses induced by SARS-CoV nucleocapsid DNA immunization

1 reference

12 December 2020

Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters

1 reference

12 December 2020

Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus

1 reference

12 December 2020

Cynomolgus macaque as an animal model for severe acute respiratory syndrome

1 reference

12 December 2020

A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity

1 reference

12 December 2020

Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein.

1 reference

12 December 2020

Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design

1 reference

12 December 2020

Is there an ideal animal model for SARS?

1 reference

12 December 2020

Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants

1 reference

12 December 2020

Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain

1 reference

12 December 2020

SARS: systematic review of treatment effects

1 reference

12 December 2020

Animal models for SARS.

1 reference

12 December 2020

Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro.

1 reference

12 December 2020

Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor

1 reference

12 December 2020

Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse

1 reference

12 December 2020

Core structure of S2 from the human coronavirus NL63 spike glycoprotein

1 reference

12 December 2020

Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants

1 reference

12 December 2020

Pathology and pathogenesis of severe acute respiratory syndrome

1 reference

12 December 2020

Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease

1 reference

12 December 2020

Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies

1 reference

12 December 2020

Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry

1 reference

12 December 2020

Pathogenetic mechanisms of severe acute respiratory syndrome.

1 reference

12 December 2020

Severe acute respiratory syndrome coronavirus infection in vaccinated ferrets

1 reference

12 December 2020

Protection from infection with severe acute respiratory syndrome coronavirus in a Chinese hamster model by equine neutralizing F(ab')2.

1 reference

12 December 2020

Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection.

1 reference

12 December 2020

Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine

1 reference

12 December 2020

Amino acid substitutions in the S2 subunit of mouse hepatitis virus variant V51 encode determinants of host range expansion

1 reference

12 December 2020

Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge

1 reference

12 December 2020

Engineering attenuated virus vaccines by controlling replication fidelity

1 reference

12 December 2020

Pathology of experimental SARS coronavirus infection in cats and ferrets

1 reference

12 December 2020

Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines

1 reference

12 December 2020

An immunosuppressed Syrian golden hamster model for SARS-CoV infection

1 reference

12 December 2020

Rhesus angiotensin converting enzyme 2 supports entry of severe acute respiratory syndrome coronavirus in Chinese macaques

1 reference

12 December 2020

T cell responses to whole SARS coronavirus in humans

1 reference

12 December 2020

MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.

1 reference

12 December 2020

The spike protein of SARS-CoV--a target for vaccine and therapeutic development

1 reference

12 December 2020

Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection.

1 reference

12 December 2020

SARS vaccines: where are we?

1 reference

12 December 2020

Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice

1 reference

12 December 2020

T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice

1 reference

12 December 2020

Effects of respiratory syncytial virus infection and major basic protein derived from eosinophils in pulmonary alveolar epithelial cells (A549).

1 reference

12 December 2020

Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques

1 reference

12 December 2020

Fully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (SARS) coronavirus S protein neutralizes the virus in a rhesus macaque SARS model

1 reference

12 December 2020

A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge

1 reference

12 December 2020

Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease

1 reference

12 December 2020

1 reference

12 December 2020

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

1 reference

12 December 2020

A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease

1 reference

12 December 2020

The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies

1 reference

12 December 2020

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

1 reference

12 December 2020

Pneumonia from human coronavirus in a macaque model

1 reference

12 December 2020

Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures

1 reference

12 December 2020

Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein

1 reference

12 December 2020

Hospital outbreak of Middle East respiratory syndrome coronavirus

1 reference

12 December 2020

Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development

1 reference

12 December 2020

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26.

1 reference

12 December 2020

Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4

1 reference

12 December 2020

The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters

1 reference

12 December 2020

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

1 reference

12 December 2020

Crystal Structure of the Receptor-Binding Domain from Newly Emerged Middle East Respiratory Syndrome Coronavirus

1 reference

12 December 2020

Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)--possible lessons from a systematic review of SARS-CoV therapy

1 reference

12 December 2020

Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques

1 reference

12 December 2020

Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2.

1 reference

12 December 2020

Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis

1 reference

12 December 2020

Structure of the Fusion Core and Inhibition of Fusion by a Heptad Repeat Peptide Derived from the S Protein of Middle East Respiratory Syndrome Coronavirus

1 reference

12 December 2020

Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment.

1 reference

12 December 2020

Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor

1 reference

12 December 2020

Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus

1 reference

12 December 2020

A decade after SARS: strategies for controlling emerging coronaviruses

1 reference

12 December 2020

An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus

1 reference

12 December 2020

Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus

1 reference

12 December 2020

Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays

1 reference

12 December 2020

Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor

1 reference

12 December 2020

Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection

1 reference

12 December 2020

Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia

1 reference

12 December 2020

Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection

1 reference

12 December 2020

Rapid generation of a mouse model for Middle East respiratory syndrome

1 reference

12 December 2020

A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein.

1 reference

12 December 2020

Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response.

1 reference

12 December 2020

Current advancements and potential strategies in the development of MERS-CoV vaccines

1 reference

12 December 2020

Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description

1 reference

12 December 2020

Evidence for camel-to-human transmission of MERS coronavirus

1 reference

12 December 2020

Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4.

1 reference

12 December 2020

Infection with MERS-CoV causes lethal pneumonia in the common marmoset

1 reference

12 December 2020

Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice

1 reference

12 December 2020

Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia

1 reference

12 December 2020

An observational, laboratory-based study of outbreaks of middle East respiratory syndrome coronavirus in Jeddah and Riyadh, kingdom of Saudi Arabia, 2014.

1 reference

12 December 2020

Receptor recognition mechanisms of coronaviruses: a decade of structural studies

1 reference

12 December 2020

Protease inhibitors targeting coronavirus and filovirus entry

1 reference

12 December 2020

2014 MERS-CoV outbreak in Jeddah--a link to health care facilities

1 reference

12 December 2020

Coronaviruses: an overview of their replication and pathogenesis.

1 reference

12 December 2020

Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits

1 reference

12 December 2020

Middle East respiratory syndrome.

1 reference

12 December 2020

Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015.

1 reference

12 December 2020

Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset

1 reference

12 December 2020

Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways

1 reference

12 December 2020

Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus

1 reference

12 December 2020

Evaluation of candidate vaccine approaches for MERS-CoV.

1 reference

12 December 2020

Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease

1 reference

12 December 2020

A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.

1 reference

12 December 2020

A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence

1 reference

12 December 2020

Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract: Implications for the Middle East Respiratory Syndrome

1 reference

12 December 2020

Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge

1 reference

12 December 2020

Spatiotemporal interplay of severe acute respiratory syndrome coronavirus and respiratory mucosal cells drives viral dissemination in rhesus macaques.

1 reference

12 December 2020

An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels

1 reference

12 December 2020

Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus

1 reference

12 December 2020

Differential Expression of the Middle East Respiratory Syndrome Coronavirus Receptor in the Upper Respiratory Tracts of Humans and Dromedary Camels

1 reference

12 December 2020

Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).

1 reference

12 December 2020

Infection, Replication, and Transmission of Middle East Respiratory Syndrome Coronavirus in Alpacas

1 reference

12 December 2020

Experimental Infection and Response to Rechallenge of Alpacas with Middle East Respiratory Syndrome Coronavirus

1 reference

12 December 2020

MERS-CoV vaccine candidates in development: The current landscape

1 reference

12 December 2020

Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses

1 reference

12 December 2020

Response to Emergence of Middle East Respiratory Syndrome Coronavirus, Abu Dhabi, United Arab Emirates, 2013-2014.

1 reference

12 December 2020

SARS and MERS: recent insights into emerging coronaviruses

1 reference

12 December 2020

MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2.

1 reference

12 December 2020

Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates

1 reference

12 December 2020

Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants

1 reference

12 December 2020

A mouse model for MERS coronavirus-induced acute respiratory distress syndrome

1 reference

12 December 2020

The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection

1 reference

12 December 2020

Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC.

1 reference

12 December 2020

MERS-CoV spike protein: a key target for antivirals

1 reference

12 December 2020

Comparative pathology of rhesus macaque and common marmoset animal models with Middle East respiratory syndrome coronavirus

1 reference

12 December 2020

DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice

1 reference

12 December 2020

Domestic Pig Unlikely Reservoir for MERS-CoV.

1 reference

12 December 2020

Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein

1 reference

12 December 2020

Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice

1 reference

12 December 2020

Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset.

1 reference

12 December 2020

Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology

1 reference

12 December 2020

Permissivity of Dipeptidyl Peptidase 4 Orthologs to Middle East Respiratory Syndrome Coronavirus Is Governed by Glycosylation and Other Complex Determinants

1 reference

12 December 2020

MERS, SARS and other coronaviruses as causes of pneumonia.

1 reference

12 December 2020

Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus.

1 reference

12 December 2020

Current understanding of middle east respiratory syndrome coronavirus infection in human and animal models

1 reference

12 December 2020

High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia

1 reference

12 December 2020

Origin and evolution of pathogenic coronaviruses

1 reference

12 December 2020